Subclinical CNS inflammation as response to a myelin antigen in humanized mice

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 4, 2013, Pages 1037-1047

  Zayoud, Morad ^a   El Malki, Khalifa ^a   Frauenknecht, Katrin ^a   Trinschek, Bettina ^a   Kloos, Luise ^a   Karram, Khalad ^a   Wanke, Florian ^a   Georgescu, Julia ^b   Hartwig, Udo F ^a   Sommer, Clemens ^a   Jonuleit, Helmut ^a   Waisman, Ari ^a   Kurschus, Florian C ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

EAE; Humanized mice; moDC; MOG; NSG

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BRAIN TISSUE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; SPINAL CORD;

ANIMALS; ANTIGENS, CD; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; T-LYMPHOCYTES;

EID: 84882260740     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9466-4     Document Type: Article

References (48)

1. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14(9):1142-1149
2. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M et al (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393-404
3. Balazs AB, Chen J, Hong CM, Rao DS, Yang L, Baltimore D (2012) Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481(7379):81-84
4. Becker C, Taube C, Bopp T, Michel K, Kubach J, Reuter S et al (2009) Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4 + CD25+ regulatory T cells. Blood 114(6):1263-1269
5. Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J et al (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75(2):77-88
6. Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J et al (2010) Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol 135(1):84-98
7. Bruno R, Sabater L, Sospedra M, Ferrer-Francesch X, Escudero D, Martinez-Caceres E et al (2002) Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur J Immunol 32(10):2737-2747
8. Cardona AE, Huang D, Sasse ME, Ransohoff RM (2006) Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat Protoc 1(4):1947-1951
9. Codarri L, Gyulveszi G, Tosevski V, Hesske L, Fontana A, Magnenat L et al (2011) RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12(6):560-567
10. Constantinescu CS, Farooqi N, O'Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079-1106
11. Croxford AL, Kurschus FC, Waisman A (2011) Mouse models for multiple sclerosis: Historical facts and future implications. Biochim Biophys Acta 1812(2):177-183
12. El-Behi M, Ciric B, Dai H, Yan Y, Cullimore M, Safavi F et al (2011) The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12(6):568-575
13. Friese MA, Montalban X, Willcox N, Bell JI, Martin R, Fugger L (2006) The value of animal models for drug development in multiple sclerosis. Brain 129(Pt 8):1940-1952
14. Harui A, Kiertscher SM, Roth MD (2011) Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation. J Neuroimmune Pharmacol 6(1):148-157
15. Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C (2001) T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36(2):220-234
16. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E et al (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27(12):3135-3142
17. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192(9):1213-1222
18. Kamath AT, Henri S, Battye F, Tough DF, Shortman K (2002) Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100(5):1734-1741
19. King IL, Dickendesher TL, Segal BM (2009) Circulating Ly-6C + myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113(14):3190-3197
20. King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M et al (2008) A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol 126(3):303-314
21. Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A et al (2009) Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med 15(6):626-632
22. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL et al (2008) T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134(4):577-586
23. Kurschus FC, Wortge S, Waisman A (2011) Modeling a complex disease: multiple sclerosis. Adv Immunol 110:111-137
24. Lagasse E, Weissman IL (1997) Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89(7):1021-1031
25. Lindert RB, Haase CG, Brehm U, Linington C, Wekerle H, Hohlfeld R (1999) Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain: J Neurol 122(Pt 11):2089-2100
26. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130(3):443-454
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408
28. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707-717
29. Martin H, Reuter S, Dehzad N, Heinz A, Bellinghausen I, Saloga J et al (2012) CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease. J Allergy Clin Immunol 129(2):521-528, 528 e521-527
30. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172(5):2731-2738
31. Mosier DE, Gulizia RJ, Baird SM, Wilson DB (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335(6187):256-259
32. Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G et al (1990) Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci U S A 87(20):7968-7972
33. Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bosl MR, Dunn R et al (2009) Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J Exp Med 206(6):1303-1316
34. Roep BO, Buckner J, Sawcer S, Toes R, Zipp F (2012) The problems and promises of research into human immunology and autoimmune disease. Nat Med 18(1):48-53
35. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214-219
36. Schluesener HJ, Wekerle H (1985) Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J Immunol 135(5):3128-3133
37. Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7(2):118-130
38. Sonar SS, Hsu YM, Conrad ML, Majeau GR, Kilic A, Garber E et al (2010) Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J Clin Investig 120(8):2767-2781
39. Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, Pleasure D (2009) Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci: Off J Soc Neurosci 29(47):14965-14979
40. Steinman L, Zamvil SS (2006) How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60(1):12-21
41. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD et al (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355(10):1018-1028
42. t Hart BA, Gran B, Weissert R (2011) EAE: imperfect but useful models of multiple sclerosis. Trends Mol Med 17(3):119-125
43. van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MC, de Weger RA, Canninga-van Dijk MR et al (2003) A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. Blood 102(7):2522-2531
44. Wekerle H, Flugel A, Fugger L, Schett G, Serreze D (2012) Autoimmunity's next top models. Nature Med 18(1):66-70
45. Wekerle H, Kurschus FC (2006) Animal models of multiple sclerosis. Drug Disc Today: Dis Models 3(4):359-367
46. Wiendl H, Hohlfeld R (2009) Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes. Neurology 72(11):1008-1015
47. Zehntner SP, Brickman C, Bourbonniere L, Remington L, Caruso M, Owens T (2005) Neutrophils that infiltrate the central nervous system regulate T cell responses. J Immunol 174(8):5124-5131
48. Zhou D, Srivastava R, Nessler S, Grummel V, Sommer N, Bruck W et al (2006) Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A 103(50):19057-19062